Udenyca 70114-0120

Generic: Pegfilgrastim-Cbqv

Product NDC

70114-0120

Manufacturer: Coherus Oncology, Inc.
Dosage Form: Injection, Solution
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: March 6, 2023
Listing Expires: December 31, 2026
Application: BLA761039

Need to source Udenyca? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Pegfilgrastim	6 mg/.6mL

Drug Class

Leukocyte Growth Factor [EPC]Granulocyte Colony-Stimulating Factor [CS]Increased Myeloid Cell Production [PE]

Packaging Options(1)

70114-0120-01

1 SYRINGE in 1 CARTON (70114-120-01) / .6 mL in 1 SYRINGE

View →